Class II · Moderate risk
Leucovorin Calcium for Injection
Lack of Assurance of Sterility
FDA drug recalls in 2021
Every FDA drug recall initiated in 2021, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,152 recalls, newest first.
Class II · Moderate risk
Octreotide Acetate Injection 50 mcg/mL
Lack of Assurance of Sterility
Class II · Moderate risk
Octreotide Acetate Injection 100 mcg/mL
Lack of Assurance of Sterility
Class II · Moderate risk
Methylprednisolone Acetate Injectable Suspension USP
Lack of Assurance of Sterility
Class II · Moderate risk
Alprostadil Injection USP
Lack of Assurance of Sterility
Class II · Moderate risk
Metoclopramide Injection USP
Lack of Assurance of Sterility
Class II · Moderate risk
Adenosine Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Norepinephrine Bitartrate Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Epoprostenol Sodium for Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Leucovorin Calcium for Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Octreotide Acetate Injection 1000 mcg/5mL
Lack of Assurance of Sterility
Class II · Moderate risk
Vecuronium Bromide for Injection 10 mg
Lack of Assurance of Sterility
Class II · Moderate risk
Idarubicin Hydrochloride Injection 20 mg/20 mL
Lack of Assurance of Sterility
Class II · Moderate risk
Amikacin Sulfate Injection USP 1 gram/4mL
Lack of Assurance of Sterility
Class II · Moderate risk
Haloperidol Decanoate Injection 100 mg/mL
Lack of Assurance of Sterility
Class II · Moderate risk
Methylprednisolone Acetate Injectable Suspension USP
Lack of Assurance of Sterility
Class II · Moderate risk
DAUNOrubicin Hydrochloride Injection 20 mg/4mL
Lack of Assurance of Sterility
Class II · Moderate risk
GaviLyteTM - C PEG-3350
Failed Stability Specification; Out of specification for Osmolarity
Class II · Moderate risk
Ethosuximide Oral Solution USP 250 mg/5 mL
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Class II · Moderate risk
Cimetidine Hydrochloride Oral Solution 300 mg/5 mL
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Class II · Moderate risk
Nystatin Oral Suspension
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Class II · Moderate risk
Venlafaxine Tablets
Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg
Class II · Moderate risk
GoodSense Aller.Ease
Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II · Moderate risk
CVS Allergy Relief
Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II · Moderate risk
Kirkland Aller-Fex
Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.